Exploring the Role of Mast Cells in Eosinophilic Esophagitis

Immunology and Allergy Clinics of North America

Volumn 29, Issue 1, 2009, Pages 189-195

  Wershil, Barry K ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Eosinophils; Esophagitis; Mast cells; Mediators

Indexed keywords

CELL FUNCTION; CYTOLOGY; DIGESTIVE SYSTEM INFLAMMATION; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; HUMAN; IMMUNOMODULATION; MAST CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DEGRANULATION; CELL MOVEMENT; CHEMOTACTIC FACTORS, EOSINOPHIL; COMPLEMENT SYSTEM PROTEINS; EOSINOPHILIA; ESOPHAGITIS; HUMANS; HYPERSENSITIVITY; MAST CELLS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149269483     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2008.09.006     Document Type: Review

References (26)

1. Galli S.J., Grimbaldeston M., and Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8 6 (2008) 478-486
2. Leslie M. Mast cells show their might. Science 317 5838 (2007) 614-616
3. Galli S.J., Zsebo K.M., and Geissler E.N. The kit ligand, stem cell factor. Adv Immunol 55 (1994) 1-96
4. Irani A.A., Schechter N.M., Craig S.S., et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 83 12 (1986) 4464-4468
5. Bischoff S.C., Wedemeyer J., Herrmann A., et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28 1 (1996) 1-13
6. Tung H.N., Schulze-Delrieu K., and Shirazi S. Infiltration of hypertrophic esophageal smooth muscle by mast cells and basophils. J Submiscrosc Cytol Pathol 25 (1993) 93-102
7. Nicholson A.G., Li D., Pastorino U., et al. Full thickness eosinophilia in oesophageal leiomyomatosis and idiopathic eosinophilic oesophagitis. A common allergic inflammatory profile?. J Pathol 183 2 (1997) 233-236
8. Paterson W.G. Role of mast cell-derived mediators in acid-induced shortening of the esophagus. Am J Phys 274 2 Pt 1 (1998) G385-G388
9. Quist R.G., Ton-Nu H.T., Lillienau J., et al. Activation of mast cells by bile acids. Gastroenterology 101 2 (1991) 446-456
10. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 4 10 (2004) 787-799
11. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
12. Blanchard C., and Rothenberg M.E. Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 18 1 (2008) 133-143 x
13. Straumann A., Bauer M., Fischer B., et al. Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Allergy Clin Immunol 108 6 (2001) 954-961
14. Blanchard C., Wang N., Stringer K.F., et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116 2 (2006) 536-547
15. Kirsch R., Bokhary R., Marcon M.A., et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 44 1 (2007) 20-26
16. Gupta S.K., Fitzgerald J.F., Kondratyuk T., et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 42 1 (2006) 22-26
17. Lucendo A.J., Navarro M., Comas C., et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol 31 4 (2007) 598-606
18. Chehade M., Sampson H.A., Morotti R.A., et al. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 45 3 (2007) 319-328
19. Konikoff M.R., Noel R.J., Blanchard C., et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131 5 (2006) 1381-1391
20. Shpacovitch V., Feld M., Hollenberg M.D., et al. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 83 6 (2008) 1309-1322
21. Ellyard J.I., Simson L., Bezos A., et al. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J Biol Chem 282 20 (2007) 15238-15247
22. Mishra A., Wang M., Pemmaraju V.R., et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 134 1 (2008) 204-214
23. Zarate N., Wang X.Y., Tougas G., et al. Intramuscular interstitial cells of Cajal associated with mast cells survive nitrergic nerves in achalasia. Neurogastroenterol Motil 18 7 (2006) 556-568
24. Wang X.Y., Zarate N., Soderholm J.D., et al. Ultrastructural injury to interstitial cells of Cajal and communication with mast cells in Crohn's disease. Neurogastroenterol Motil 19 5 (2007) 349-364
25. Tsai M., Grimbaldeston M.A., Yu M., et al. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo. Chem Immunol Allergy 87 (2005) 179-197
26. Metz M., Grimbaldeston M.A., Nakae S., et al. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 217 (2007) 304-328